Cocrystal Pharma, Inc.

US$1.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:COCPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (39.97%)
Div yield —
ROE (311.68%)
Biotechnology
Beta (5Y) 1.61
PE TTM —
TSR TTM (4.59%)
Mkt cap US$20.03M
ROIC (134.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.26
21.41%
142.41%
Buy 2|0|1|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
19.04%
15.78%
21.56%
31.52%
Revenue$M
1.213
1.231
1.293
1.307
9.69%
5.89%
9.29%
6.58%
Peers (US$20.03M)
Cap (US$)
PE
20.68M
—
20.20M
—
Capital
TTM
5Y
10Y
Leveragex
1.001
0.158
0.131
EBIT/Intx
0.190
0.130
0.114
Own earn%
409.17
276.70
268.06
Sh yield%
43.62
53.51
54.56
Owners
Insiders/Inst%
0.75
73.71
Short interest%
1.91
SBC / revenue%
3.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
11